FBI NGI April 2019 Fact Sheet Statistics:

• The FBI Next Generation Identification (NGI) database
contains the fingerprints of over 141 million individuals
(both civil and criminal).
•  Over 97% of the Tenprint Rapsheet Request (TPRS)
responses were completed within 20 seconds.
Fiscal Year 2019 Average

In Touch 
with 
Your World

FREEDOM TO TRAVEL ABROAD

For the Pharma Technology Industry

FBI fingerprint-based background checks are increasingly required for U.S. Citizens to live, work and travel overseas in many countries such as China,South Korea, Australia, South Africa, Spain and Israel.

Accurate Biometrics is an authorized FBI Channeler, providing access to FBI Identity History Summary Checks (IdHS), or Departmental Orders (556-73).

Our expertise will assist your company:

  • Obtain access to Identity History Summary Checks for Visa requirements direct from the FBI CJIS
  • National U.S. Collection Network, over 700 locations in 50 states
  • SAME DAY International fingerprint card processing
  • NEW! FBI Channeling Cloud Technology
  • Customized solution-based service to public and private companies to meet their fingerprinting needs

For more information on how to improve your current fingerprint process, contact...

Will Peterson 
Director of Business Development
708-887-9258
wpeterson@accuratebiometrics.com
AccurateBiometrics.com

Go to article: Home | Taming the pharma beastGo to article: In this issueGo to article: Emirates SkyCargoGo to article: ContentsGo to article: TSS Company InsightGo to article: NewsGo to article: Daiichi JitsugyoGo to article: ICCI Company InsightGo to article: ICCIGo to article: The pharma industry briefingGo to article: Novo NordiskGo to article: Swiss WorldCargoGo to article: Understanding drug-resistant TBGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Through time: the breakthroughs that changed the course of HIV treatmentGo to article: Senn ChemicalsGo to article: Qatar AirwaysGo to article: Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woesGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The dangers of unlicensed stem cell clinicsGo to article: Komtur PharmaceuticalsGo to article: How do cancer cells communicate and can it help us catch them?Go to article: Verona’s ensifentrine: a potentially revolutionary treatment for COPDGo to article: Taming the pharma monster with Hedley ReesGo to article: Capsugel Company InsightGo to article: Altheria SolutionsGo to article: ‘Pay As You Go’ AI for drug discoveryGo to article: AtoZ-CRO GmbHGo to article: PharmaHempGo to article: Event: CPhl KoreaGo to article: EventsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Next issueGo to article: Hapa Company InsightGo to article: Pfanstiehl